ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

April 23, 2004

GAO Report Refutes Charges Against Control Program

May 30, 1980

Going private may allow US Oncology to restructure, respond to Medicare cuts; equity investment firm offers to purchase shares.

April 23, 2004

In Brief

February 7, 2014

HCFA Abadons Plan To Cut Cancer Drug Payments.

September 15, 2000

Amgen, Genentech Drug Giveaway Programs Likely to Meet Resistance From Doctors, Potential Problems at CMS.

October 13, 2006